| Home Page |
| References | OMIM | Gene | GeneReviews | HGMD | HGNC |
| GENATLAS PHENOTYPE |
| last update : 30-05-2012 |
| Symbol | DEL17Q21 |
| Location | 17q21.31 |
| Name | chromosome 17q21.31 microdeletion syndrome |
| Other name(s) | KANSL1-Related Intellectual Disability Syndrome; monosomy 17q21 |
| Corresponding gene | MAPT , CRHR1 , KANSL1 |
| Main clinical features |
|
| Genetic determination | chromosomal |
| genomic disorder | |
| Prevalence | 1 in 16 000 births |
| Function/system disorder | multisystem/generalized |
| mental retardation | |
| Type | MCA/MR |
| Gene product |
| Name | the KANSL1 protein is an evolutionarily conserved regulator of the chromatin modifier KAT8, which influences gene expression through histone H4 lysine 16 (H4K16) acetylation |
| Mechanism(s) |
| Gene mutation | Chromosome rearrangement | Effect | Comments |
|  
| deletion
| haploinsufficiency
| microdeletion with a critical region of 424kb
| various types
|  
| haploinsufficiency
| in the KANSL1 gene PMID: 22544367, PMID: 22544363
| |
| Remark(s) | several low-copy repeats, recently associated with a 900 kb inversion present in up to 20 percent of European subjects, are present in 17q21.31; this inversion is present in all examined parent originating the deletion ; the deleted region contains the MAPT gene, implicated in late onset neurodegenerative disorders, and other genes; haploinsufficiency of KANSL1 is sufficient to cause the classical 17q21.31 microdeletion syndrome phenotype PMID: 22544367,, PMID: 22544363 ; |
| Genotype/Phenotype correlations | patients carrying larger or non-overlapping deletions in this region have also been described with different manifestations |